DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Intron A (Interferon Alfa-2B) - Serious Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Events (129)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Intron A (Interferon Alfa-2B) serious events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 129   Next >>

Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-24

Patient:

Reactions: Salmonella Sepsis, Cardiac Flutter, Liver Function Test Abnormal, Lower Respiratory Tract Infection, Post Procedural Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Dosage: 40 million iu, unknown
    Indication: Malignant Melanoma
    Start date: 2011-08-29

Intron A
    Dosage: unk unk, unknown
    Start date: 2011-10-16

Intron A
    Dosage: 22.6 million iu, tiw
    Start date: 2011-10-03

Intron A
    Dosage: 30 million iu, unknown

Intron A
    Dosage: 22.6 million iu, tiw
    Start date: 2011-10-06
    End date: 2011-12-01

Intron A
    Dosage: 22.6 million iu, tiw
    Start date: 2012-01-16

Intron A
    Dosage: 22.5 million iu, tiw
    Start date: 2012-05-07
    End date: 2012-07-16

Other drugs received by patient: Acetaminophen; Micardis; Amlodipine Besylate; Amlodipine Besylate; Bismuth Subnitrate (+) Calcium Carbonate (+) Phenobarbital (+) Sodium; Ondansetron



Possible Intron A side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Malaise, Fatigue, Renal Disorder, Blood Creatinine Increased, Loss of Consciousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Diovan; Amlodipine; Allopurinol; Lipitor; Renvela



Possible Intron A side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Drug Ineffective, Retinal Oedema, Visual Impairment, Oedema Peripheral, Malignant Melanoma, Crying

Drug(s) suspected as cause:
Intron A
    Dosage: 3 df, qd
    Indication: Hepatitis C
    Start date: 1992-08-07
    End date: 1993-08-06

Rebetol
    Dosage: unk
    Administration route: Oral
    Start date: 2012-06-21

Rebetol
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 1992-08-07
    End date: 1993-08-06

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-20

Other drugs received by patient: Pegasys



Possible Intron A side effects in

Reported by a physician from Spain on 2012-08-23

Patient:

Reactions: Drug Ineffective, Drug Rash With Eosinophilia and Systemic Symptoms

Drug(s) suspected as cause:
Intron A
    Dosage: unk
    Start date: 1999-01-01

Intron A
    Dosage: 3 mu, tiw
    Start date: 1992-09-01
    End date: 1993-03-01

Intron A
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-06

Ribavirin
    Dosage: unk
    Start date: 1999-01-01

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 2012-02-01
    End date: 2012-03-13

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 1994-03-01

Ribavirin
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Telaprevir
    Dosage: 750 mg, q8h
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-10

Other drugs received by patient: Trandolapril; Verapamil; Moxonidine; Telmisartan



Possible Intron A side effects in

Reported by a physician from Spain on 2012-08-22

Patient:

Reactions: Drug Ineffective, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms

Drug(s) suspected as cause:
Intron A
    Dosage: unk
    Start date: 1999-01-01

Intron A
    Dosage: 3 mu, tiw
    Start date: 1992-09-01
    End date: 1993-03-01

Intron A
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-06

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 2012-02-01
    End date: 2012-03-13

Ribavirin
    Dosage: 1200 mg, qd
    Start date: 1994-03-01

Ribavirin
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Ribavirin
    Dosage: unk
    Start date: 1999-01-01

Telaprevir
    Dosage: 750 mg, q8h
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-10

Other drugs received by patient: Verapamil; Trandolapril; Moxonidine; Telmisartan



Possible Intron A side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-21

Patient: male, weighing 114.8 kg (252.5 pounds)

Reactions: Cellulitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a consumer/non-health professional from United States on 2012-08-15

Patient:

Reactions: Malignant Melanoma

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a physician from United States on 2012-08-13

Patient:

Reactions: Vomiting, Drug Ineffective, Pain in Extremity, Somnolence, Ulcer, Diarrhoea, Blood Potassium Decreased, Dehydration

Drug(s) suspected as cause:
Intron A
    Dosage: unk unk, q3w
    Indication: Hepatitis C
    Start date: 2001-09-28
    End date: 2002-09-27

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2001-09-28
    End date: 2002-09-27



Possible Intron A side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-13

Patient: male, weighing 115.0 kg (253.0 pounds)

Reactions: Blood Creatine Phosphokinase Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-07

Patient:

Reactions: Death, Poor Quality Sleep, Fatigue, Skin Lesion, Rash, Disease Progression, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Methotrexate



Possible Intron A side effects in

Reported by a consumer/non-health professional from United Kingdom on 2012-08-06

Patient:

Reactions: Abortion Spontaneous, Exposure VIA Father

Drug(s) suspected as cause:
Intron A
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Intron A side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-02

Patient: male, weighing 76.7 kg (168.7 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Therapy Cessation, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-01

Patient:

Reactions: Death, Poor Quality Sleep, Fatigue, Skin Lesion, Rash, Decreased Appetite, Disease Progression

Adverse event resulted in: death

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Methotrexate



Possible Intron A side effects in male

Reported by a physician from United States on 2012-07-31

Patient: male, weighing 112.0 kg (246.4 pounds)

Reactions: Weight Decreased, Abdominal Pain, Nausea, Chills, Dysstasia, Fatigue, Diarrhoea, Dehydration, Dizziness, Fluid Intake Reduced

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-30

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Fatigue, Nausea, Abnormal Behaviour, Cognitive Disorder, Memory Impairment, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a physician from United States on 2012-07-26

Patient:

Reactions: Pancreatitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A

Rebetol

Victrelis
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-07-23



Possible Intron A side effects in female

Reported by a physician from United States on 2012-07-26

Patient: female, weighing 83.6 kg (183.9 pounds)

Reactions: Vomiting, Diarrhoea, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-07-24

Patient:

Reactions: Poor Quality Sleep, Death, Fatigue, Skin Lesion, Rash, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Methotrexate



Possible Intron A side effects in

Reported by a physician from Japan on 2012-07-23

Patient:

Reactions: Tracheal Papilloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a physician from United States on 2012-07-23

Patient: female, weighing 96.6 kg (212.5 pounds)

Reactions: Rhabdomyolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a physician from United States on 2012-07-20

Patient: female, weighing 83.6 kg (183.9 pounds)

Reactions: Vomiting, Diarrhoea, Nausea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a physician from Spain on 2012-07-20

Patient:

Reactions: Drug Ineffective, Pyrexia, Drug Rash With Eosinophilia and Systemic Symptoms

Drug(s) suspected as cause:
Intron A
    Dosage: unk
    Start date: 1999-01-01

Intron A
    Dosage: 6 miu, tiw, lymphoblastoid injection
    Start date: 1993-01-01

Intron A
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Intron A
    Dosage: 3 mu, tiw
    Indication: Hepatitis C
    Start date: 1992-09-01
    End date: 1993-03-01

PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-06

Rebetol
    Dosage: 1200 mg, qd
    Indication: Hepatitis C
    Start date: 1994-03-01

Rebetol
    Dosage: unk
    Start date: 1999-01-01

Rebetol
    Dosage: 1200 mg, qd
    Start date: 2012-02-01
    End date: 2012-03-13

Rebetol
    Dosage: unk
    Start date: 1996-02-01
    End date: 1996-05-01

Telaprevir
    Dosage: 750 mg, q8h
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-03-10

Other drugs received by patient: Moxonidine; Verapamil; Telmisartan; Trandolapril



Possible Intron A side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-19

Patient: male, weighing 102.7 kg (225.9 pounds)

Reactions: Atelectasis, Cholelithiasis, Proteinuria, Pancreatitis, Headache, Axillary Mass, Lung Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A

Other drugs received by patient: Zithromax; Rocephni



Possible Intron A side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-18

Patient: male, weighing 102.7 kg (225.9 pounds)

Reactions: Tumour Necrosis, Atelectasis, Nausea, Retching, Headache, Axillary Mass, Cyst, Cholelithiasis, Proteinuria, Hypoxia, Pancreatitis, Abscess, Lung Infiltration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in

Reported by a physician from Belgium on 2012-07-18

Patient:

Reactions: Toxicity To Various Agents

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in 53 year old male

Reported by a physician from Japan on 2012-07-17

Patient: 53 year old male

Reactions: Anaemia Haemolytic Autoimmune

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Indication: Hepatitis C

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C



Possible Intron A side effects in male

Reported by a physician from United States on 2012-07-16

Patient: male, weighing 81.6 kg (179.5 pounds)

Reactions: Back Pain

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Confusional State, Vomiting, Malaise, Nausea, Urinary Tract Infection, Dehydration, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a physician from United States on 2012-07-12

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Confusional State, Vomiting, Nausea, Urinary Tract Infection, Autoimmune Disorder, Malaise, Dehydration, Hypophagia, Feeling Abnormal, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A



Possible Intron A side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: female

Reactions: Mass, Drug Ineffective, Coma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Intron A
    Start date: 1999-01-01

Intron A
    Start date: 2011-10-22

Ribavirin
    Indication: Hepatitis C
    Start date: 1999-01-01

Ribavirin
    Indication: Hepatitis C
    Start date: 2011-10-22



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012